Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $19.9000 (-0.85%) ($19.6400 - $20.4500) on Wed. Oct. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.63% (three month average) | RSI | 7 | Latest Price | $19.9000(-0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.315% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.315% (StdDev 2.63%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
1 - 5 Day Possible Target | $5.76(-71.06%) | Resistance Level | $23.23 | 5 Day Moving Average | $20.95(-5.01%) | 10 Day Moving Average | $21.59(-7.83%) | 20 Day Moving Average | $23.23(-14.33%) | To recent high | -25.8% | To recent low | 0% | Market Cap | $1.236b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |